Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | MMP2 | P08253 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | FDPS | P14324 | 5/20 | 0.42 |
| ▸ | LAP3 | P28838 | 1/20 | 0.42 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.40 |
| ▸ | MMP1 | P03956 | 2/20 | 0.40 |
| ▸ | MMP3 | P08254 | 2/20 | 0.40 |
| ▸ | MMP8 | P22894 | 2/20 | 0.40 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.40 |
| ▸ | MMP9 | P14780 | 1/20 | 0.40 |
| ▸ | TYMS | P04818 | 1/20 | 0.38 |
| ▸ | PPARD | Q03181 | 1/20 | 0.36 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.36 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL28548499 | 1.00 | CA2 (0.50) | CA2MMP2KDM4ETHRBMAPK1 | |
| Phosphoric Acid SCHEMBL5712813 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL6424550 | 1.00 | CA2 (0.50) | CA2MMP2KDM4ETHRBMAPK1 | |
| Phosphoric Acid SCHEMBL29023367 | 1.00 | CA2 (0.50) | CA2MMP2KDM4ETHRBMAPK1 | |
| Phosphoric Acid SCHEMBL29228758 | 0.95 | CA2 (0.46) | CA2MMP2KDM4ETHRBMAPK1 | |
| Phosphoric Acid SCHEMBL28858104 | 0.95 | CA2 (0.46) | CA2MMP2KDM4ETHRBMAPK1 | |
| Phosphoric Acid SCHEMBL28911969 | 0.95 | CA2 (0.46) | CA2MMP2KDM4ETHRBMAPK1 | |
| Phosphoric Acid SCHEMBL28811859 | 0.95 | CA2 (0.46) | CA2MMP2KDM4ETHRBMAPK1 | |
| Phosphoric Acid SCHEMBL28934959 | 0.95 | CA2 (0.46) | CA2MMP2KDM4ETHRBMAPK1 | |
| Phosphoric Acid SCHEMBL10789408 | 0.95 | CA2 (0.46) | CA2MMP2KDM4ETHRBMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112993289-A | Lithium/carbon fluoride battery, electrolyte thereof and use method thereof | 中国科学院大连化学物理研究所 | 2021-06-18 | — | — | CN | claimed |
| US-9453244-B2 | Method for producing a monoalkene by enzymatic conversion of an alkyl monoester | GLOBAL BIOENERGIES (FR) | 2016-09-27 | — | — | US | claimed |
| US-20150159177-A1 | METHOD FOR PRODUCING A MONOALKENE BY ENZYMATIC CONVERSION OF AN ALKYL MONOESTER | GLOBAL BIOENERGIES (FR) | 2015-06-11 | — | — | US | claimed |
| EP-2867365-A1 | PROCESS FOR PRODUCING A C2-C10 MONOALKENE EMPLOYING A TERPENE SYNTHASE OR A PRENYL TRANSFERASE | Scientist of Fortune S.A. (LU) | 2015-05-06 | — | — | EP | claimed |
| WO-2014001517-A1 | PROCESS FOR PRODUCING A C2-C10 MONOALKENE EMPLOYING A TERPENE SYNTHASE OR A PRENYL TRANSFERASE | SCIENTIST OF FORTUNE S.A. (LU) | 2014-01-03 | — | — | WO | claimed |
| CN-102161742-A | Organic polymer polyurethane elastomer and preparation method thereof | SHANGHAI POLYURETHANE PRODUCTS CO LTD | 2011-08-24 | — | — | CN | claimed |
| EP-3681504-B1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ICAGEN INC (US) | 2023-08-23 | — | — | EP | disclosed |
| US-11573224-B2 | Methods of detection using X-ray fluorescence | ICAGEN, LLC (US) | 2023-02-07 | — | — | US | disclosed |
| CN-114042009-A | Polypeptide composition with antioxidation and repair effects and application thereof | 宇肽生物(东莞)有限公司 | 2022-02-15 | — | — | CN | disclosed |
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| CN-112993289-A | Lithium/carbon fluoride battery, electrolyte thereof and use method thereof | 中国科学院大连化学物理研究所 | 2021-06-18 | — | — | CN | disclosed |
| US-10877035-B2 | Advanced drug development and manufacturing | ICAGEN, LLC (US) | 2020-12-29 | — | — | US | disclosed |
| US-20200278346-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ADJACENT ACQUISITION CO., LLC | 2020-09-03 | — | — | US | disclosed |
| EP-2084519-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | Los Alamos National Security, LLC (US) | 2009-08-05 | — | — | EP | disclosed |
| WO-2008127291-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2008-10-23 | — | — | WO | disclosed |
| US-20080220441-A1 | Advanced drug development and manufacturing | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2008-09-11 | — | — | US | disclosed |
| CN-100334228-C | Cimeric immunomodulatory compounds and methods of using the same | DYNAVAX TECH CORP (US) | 2007-08-29 | — | — | CN | disclosed |
| CN-1533442-A | Cimeric immunomodulatory compounds and methods of using the same | 戴纳瓦克斯技术公司 | 2004-09-29 | — | — | CN | disclosed |
| CN-1078073-C | Use of bisphophonates for inhibiting bone resorption following | MERCK & CO INC (US) | 2002-01-23 | — | — | CN | disclosed |
| CN-1146152-A | Use of bisphophonates for inhibiting bone resorption following | MERCK & CO INC (US) | 1997-03-26 | — | — | CN | disclosed |